Calcimedica, INC. (CALC) — 10-Q Filings

10-Q Filings (5)

• CalciMedica's Net Loss Doubles Amid Rising R&D, Cash Dwindles — Nov 12, 2025 Risk: high
  CalciMedica, Inc. (CALC) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $18.802 million, a 99.1% increase fr
• CalciMedica Posts $21.3M Net Loss, Secures $15M Loan for R&D — Aug 12, 2025 Risk: high
  CalciMedica, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company posted a net loss
• CalciMedica Files 10-Q, Details Financials — May 14, 2025 Risk: medium
  CalciMedica, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including fair value measurements for recurring
• CalciMedica, Inc. Files Q2 2024 10-Q — Aug 12, 2024 Risk: medium
  CalciMedica, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Graybug Vision, Inc., is focused on pharmaceutical preparat
• CalciMedica, Inc. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: medium
  CalciMedica, Inc. (CALC) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. CalciMedica, Inc. filed a 10-Q report for the period ending March 31, 202

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX